Osteopontin expression and relation to streptococcal disease severity in mice

References

• Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res 2004;121:228–41.
   PubMed Web of Science ®Google Scholar
• Dai J, Cao Z, Kang Y, Fan K, Ji G, Yang H, . A functional motif QLYxxYP is essential for osteopontin induced T lymphocyte activation and migration. Biochem Biophys Res Commun 2009;380:715–20.
   PubMedGoogle Scholar
• O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 2000;68:495–502.
   PubMed Web of Science ®Google Scholar
• Begum MD, Umemura M, Kon S, Yahagi A, Hamada S, Oshiro K, . Suppression of the bacterial antigen-specific T cell response and the dendritic cell migration to the lymph nodes by osteopontin. Microbiol Immunol 2007;51:135–47.
   PubMedGoogle Scholar
• Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, . Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860–4.
   PubMed Web of Science ®Google Scholar
• Vaschetto R, Nicola S, Olivieri C, Boggio E, Piccolella F, Mesturini R, . Serum levels of osteopontin are increased in SIRS and sepsis. Intensive Care Med 2008;34:2176–84.
   PubMed Web of Science ®Google Scholar
• van der Windt GJ, Hoogerwerf JJ, de Vos AF, Florquin S, van der Poll T. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J 2010 Apr 8 [Epub ahead of print].
   PubMedGoogle Scholar
• Rittling SR, Zetterberg C, Yagiz K, Skinner S, Suzuki N, Fujimura A, . Protective role of osteopontin in endodontic infection. Immunology 2010;129:105–14.
   PubMedGoogle Scholar
• Vikerfors A, Haggar A, Darenberg J, Low A, Melhus A, Hedlund J, . Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006 to 2007. Scand J Infect Dis 2009;41:823–30.
   PubMed Web of Science ®Google Scholar
• Okuno R, Endoh M, Shimojima Y, Yanagawa Y, Morozumi S, Igarashi H, . [Epidemiological study on Streptococcus pyogenes strains isolated from the patients with streptococcal toxic shock syndrome (STSS) in Japan in 1992–2001]. Kansenshogaku Zasshi 2004;78:10–7.
   PubMedGoogle Scholar
• Bouza E, Bernaldo de Quiros JC, Rodriguez Creixems M, Quintans A. Fulminant myonecrosis due to Streptococcus pyogenes in a previously healthy patient. Eur J Clin Microbiol Infect Dis 1988;7:205–6.
   PubMedGoogle Scholar
• Haywood CT, McGeer A, Low DE. Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 1999; 103:1567–73.
   PubMed Web of Science ®Google Scholar
• Norrby-Teglund A, Lustig R, Kotb M. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect Immun 1997;65:5209–15.
   PubMedGoogle Scholar
• Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 1995;27:125–30.
   PubMed Web of Science ®Google Scholar
• Diao H, Kohanawa M. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 2005;73:3745–8.
   PubMedGoogle Scholar
• Diao H, Kohanawa M, Yimin, Nakajima H, Sato Y, Minagawa T, . Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism. Immunology 2002;105: 344–9.
   PubMedGoogle Scholar
• Shin T, Ahn M, Kim H, Kim HM, Matsumoto Y. Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis. J Vet Med Sci 2006;68:379–82.
   PubMedGoogle Scholar
• Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003;107:679–81.
   PubMedGoogle Scholar
• Karcher EL, Johnson CS, Beitz DC, Stabel JR. Osteopontin immunoreactivity in the ileum and ileocecal lymph node of dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol 2008;126:142–8.
   PubMedGoogle Scholar
• Uede T, Katagiri Y, Iizuka J, Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol Immunol 1997;41: 641–8.
   PubMed Web of Science ®Google Scholar
• Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 1999;67:4223–30.
   PubMedGoogle Scholar
• Pallua N, Low JF, von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 2003;31:1495–501.
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, . IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003;4:551–6.
   PubMed Web of Science ®Google Scholar
• Samuvel DJ, Sundararaj KP, Li Y, Lopes-Virella MF, Huang Y. Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism. J Biol Chem 2010;285:3916–27.
   PubMed Web of Science ®Google Scholar